231 related articles for article (PubMed ID: 25728057)
21. Effectiveness of chemoradiation for head and neck cancer in an older patient population.
VanderWalde NA; Meyer AM; Deal AM; Layton JB; Liu H; Carpenter WR; Weissler MC; Hayes DN; Fleming ME; Chera BS
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):30-7. PubMed ID: 24725687
[TBL] [Abstract][Full Text] [Related]
22. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
23. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.
Xu B; Boero IJ; Hwang L; Le QT; Moiseenko V; Sanghvi PR; Cohen EE; Mell LK; Murphy JD
Cancer; 2015 Apr; 121(8):1303-11. PubMed ID: 25537836
[TBL] [Abstract][Full Text] [Related]
24. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.
Koutcher L; Sherman E; Fury M; Wolden S; Zhang Z; Mo Q; Stewart L; Schupak K; Gelblum D; Wong R; Kraus D; Shah J; Zelefsky M; Pfister D; Lee N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):915-22. PubMed ID: 20947269
[TBL] [Abstract][Full Text] [Related]
25. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
26. Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer.
Chen C; Kane M; Song J; Campana J; Raben A; Hu K; Harrison L; Quon H; Dancey J; Baron A; Said S; Eckhardt SG; Raben D
J Clin Oncol; 2007 Nov; 25(31):4880-6. PubMed ID: 17971583
[TBL] [Abstract][Full Text] [Related]
27. Completion of radiotherapy for local and regional head and neck cancer in medicare.
Fesinmeyer MD; Mehta V; Tock L; Blough D; McDermott C; Ramsey SD
Arch Otolaryngol Head Neck Surg; 2009 Sep; 135(9):860-7. PubMed ID: 19770417
[TBL] [Abstract][Full Text] [Related]
28. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
Davidoff AJ; Gardner JF; Seal B; Edelman MJ
J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
[TBL] [Abstract][Full Text] [Related]
29. Hypothyroidism in older patients with head and neck cancer after treatment with radiation: a population-based study.
Smith GL; Smith BD; Garden AS; Rosenthal DI; Sherman SI; Morrison WH; Schwartz DL; Weber RS; Buchholz TA
Head Neck; 2009 Aug; 31(8):1031-8. PubMed ID: 19360741
[TBL] [Abstract][Full Text] [Related]
30. Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation.
Fang FM; Tsai WL; Chien CY; Chiu HC; Wang CJ; Chen HC; Hsiung CY
Oncology; 2005; 68(4-6):405-13. PubMed ID: 16020970
[TBL] [Abstract][Full Text] [Related]
31. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
32. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
[TBL] [Abstract][Full Text] [Related]
33. Definitive altered fractionation radiotherapy and concomitant weekly cisplatin for locally advanced head and neck cancer.
Boulmay BC; Chera BS; Morris CG; Kirwan J; Riggs CE; Lawson M; Mendenhall WM
Am J Clin Oncol; 2009 Oct; 32(5):488-91. PubMed ID: 19528791
[TBL] [Abstract][Full Text] [Related]
34. Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer.
Daly ME; Lau DH; Farwell DG; Luu Q; Donald PJ; Chen AM
Am J Otolaryngol; 2013; 34(6):631-5. PubMed ID: 23954137
[TBL] [Abstract][Full Text] [Related]
35. Docetaxel in the management of patients with head and neck squamous cell carcinoma.
Bernier J; Vrieling C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449
[TBL] [Abstract][Full Text] [Related]
36. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
Datta NR; Stutz E; Liu M; Rogers S; Klingbiel D; Siebenhüner A; Singh S; Bodis S
Gynecol Oncol; 2017 May; 145(2):374-385. PubMed ID: 28188016
[TBL] [Abstract][Full Text] [Related]
37. Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatment.
McCusker MG; Mehra R; Amr S; Taylor RJ; Cullen KJ; Goloubeva OG
Head Neck; 2022 Mar; 44(3):749-759. PubMed ID: 34931731
[TBL] [Abstract][Full Text] [Related]
38. Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer.
Newlin HE; Amdur RJ; Riggs CE; Morris CG; Kirwan JM; Mendenhall WM
Cancer; 2010 Oct; 116(19):4533-40. PubMed ID: 20572028
[TBL] [Abstract][Full Text] [Related]
39. Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer.
Espeli V; Zucca E; Ghielmini M; Giannini O; Salatino A; Martucci F; Richetti A
Oral Oncol; 2012 Mar; 48(3):266-71. PubMed ID: 22079100
[TBL] [Abstract][Full Text] [Related]
40. Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.
Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
Radiat Oncol; 2015 Apr; 10():93. PubMed ID: 25896830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]